DeepMed Research

Monteris Medical

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

REMASTer: REcurrent Brain Metastases After SRS Trial

Not Applicable

Recruiting

Conditions: Brain Metastases
Radiation Necrosis
Recurrent Tumor
Recurrent Metastases

Interventions: Procedure: Radiation Therapy
Drug: Steroid Therapy
Procedure: Laser Interstitial Thermal Therapy

First Posted Date: 2021-11-18

Last Posted Date: 2024-12-05

Lead Sponsor: Monteris Medical

Target Recruit Count: 261

Registration Number: NCT05124912

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States

and more 6 locations

PatiEnt Neuropsychological outcomeS After laseR Ablation

Completed

Conditions: Cognitive Change

First Posted Date: 2021-10-13

Last Posted Date: 2025-04-06

Lead Sponsor: Monteris Medical

Target Recruit Count: 81

Registration Number: NCT05075850

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Advent Health Orlando, Orlando, Florida, United States
🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

and more 4 locations

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Phase 1

Terminated

Conditions: Glioblastoma

Interventions: Device: NeuroBlate System
Drug: Radiation therapy and temozolomide

First Posted Date: 2016-08-26

Last Posted Date: 2024-04-12

Lead Sponsor: Monteris Medical

Target Recruit Count: 3

Registration Number: NCT02880410

Locations: 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

and more 1 locations

Feasibility Study on LITT for Medical Refractory Epilepsy

Not Applicable

Terminated

Conditions: Epilepsy

Interventions: Device: NeuroBlate System

First Posted Date: 2016-07-01

Last Posted Date: 2024-07-12

Lead Sponsor: Monteris Medical

Target Recruit Count: 4

Registration Number: NCT02820740

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States
🇺🇸
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

and more 2 locations

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Completed

Conditions: Primary Brain Tumor
Epileptic/Seizure Foci
Metastatic Brain Tumor
Movement Disorders

First Posted Date: 2015-03-18

Last Posted Date: 2025-04-24

Lead Sponsor: Monteris Medical

Target Recruit Count: 1153

Registration Number: NCT02392078

Locations: 🇺🇸
The Cleveland Clinic Florida, Weston, Florida, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States

and more 23 locations

Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry

Completed

Conditions: Primary Brain Tumor

First Posted Date: 2015-03-17

Last Posted Date: 2024-04-12

Lead Sponsor: Monteris Medical

Target Recruit Count: 144

Registration Number: NCT02389855

Locations: 🇺🇸
St. Luke's Hospital, Kansas City, Missouri, United States
🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

and more 6 locations

Laser Ablation After Stereotactic Radiosurgery

Completed

Conditions: Metastatic Brain Tumors
Quality of Life
Progression
Radiation Necrosis

First Posted Date: 2012-07-26

Last Posted Date: 2024-04-15

Lead Sponsor: Monteris Medical

Target Recruit Count: 44

Registration Number: NCT01651078

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
🇺🇸
Washington University in St Louis, Saint Louis, Missouri, United States
🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

and more 4 locations

Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors

Phase 1

Completed

Conditions: Brain Cancer
Brain Tumor, Recurrent
Glioblastoma Multiforme
Brain Neoplasm
Brain Tumor
Recurrent Glioblastoma Multiforme

Interventions: Device: AutoLITT system

First Posted Date: 2008-09-05

Last Posted Date: 2021-08-24

Lead Sponsor: Monteris Medical

Target Recruit Count: 10

Registration Number: NCT00747253

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, Ohio, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy